Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021;3(12):2389-2392.
doi: 10.1007/s42399-021-01019-7. Epub 2021 Jul 20.

Frequently Relapsing Post-COVID-19 Immune Thrombocytopenia

Claudia Serrano  1 , Ignacio Español  1 , Almudena Cascales  1 , José M Moraleda  1
Affiliations
Comment

Frequently Relapsing Post-COVID-19 Immune Thrombocytopenia

Claudia Serrano et al. SN Compr Clin Med. 2021.
No abstract available

Keywords: Bleeding; ITP; Post-COVID-19; Relapses.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestThe authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Treatment offered to post-COVID-19 ITP patients. MTP, methylprednisolone (1 mg/kg/day for 7 days); RX, rituximab (375 mg/m2/week for 4 weeks); IVIg, unspecific immunoglobulins (1 g/kg/day i.v. for 2 days); DEX, dexamethasone (40 mg/day for 4 days); TP50, eltrombopag (50 mg/day daily); TP75, eltrombopag (75 mg/day every day); MMF, mycophenolate mofetil (1 g/12 h daily)
See this image and copyright information in PMC

Comment on

References

    1. Bhattacharjee S, Banerjee M. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review [published online ahead of print, 2020 Sep 19]. SN Compr Clin Med. 2020;1–11. - PMC - PubMed
    1. Sahu KK, Borogovac A, Cerny J. COVID-19 related immune hemolysis and thrombocytopenia. J Med Virol. 2021;93(2):1164–1170. - PMC - PubMed
    1. Zhang Y, Zeng X, Jiao Y, Li Z, Liu Q, Ye J, Yang M. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19. Thromb Res. 2020;193:110–115. doi: 10.1016/j.thromres.2020.06.008. - DOI - PMC - PubMed
    1. Bomhof G, Mutsaers PGNJ, Leebeek FWG, et al. COVID-19-associated immune thrombocytopenia. Br J Haematol. 2020;190(2):61–64. doi: 10.1111/bjh.16850. - DOI - PMC - PubMed
    1. Kewan T, Gunaratne TN, Mushtaq K, Alayan D, Daw H, Haddad A. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience [published online ahead of print, 2021 Mar 16]. Transfusion. 2021; 10.1111/trf.16368. - PMC - PubMed

LinkOut - more resources